George Hill
Stock Analyst at Deutsche Bank
(2.96)
# 1,604
Out of 5,044 analysts
186
Total ratings
53.98%
Success rate
6.16%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Buy | $775 → $856 | $806.88 | +6.09% | 8 | Sep 24, 2025 | |
| HQY HealthEquity | Maintains: Buy | $98 → $115 | $93.85 | +22.54% | 18 | Jun 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $521 → $362 | $368.89 | -1.87% | 22 | May 14, 2025 | |
| CVS CVS Health | Upgrades: Buy | $66 | $82.26 | -19.76% | 5 | Dec 3, 2024 | |
| AGL agilon health | Maintains: Hold | $4 → $2 | $0.92 | +116.64% | 16 | Nov 8, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $23 → $27 | $47.32 | -42.94% | 4 | Nov 6, 2024 | |
| CI The Cigna Group | Maintains: Buy | $398 → $394 | $309.36 | +27.36% | 10 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Hold | $119 → $124 | $163.04 | -23.95% | 12 | Nov 4, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $12 | $8.39 | +43.03% | 18 | Nov 1, 2024 | |
| HUM Humana | Maintains: Hold | $349 → $250 | $294.51 | -15.11% | 11 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $5.67 | -64.73% | 14 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $31 | $39.54 | -21.60% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $5 | $2.89 | +73.01% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $82 → $87 | $33.29 | +161.34% | 10 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $353 | $162.93 | +116.66% | 9 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $461 → $471 | $289.42 | +62.74% | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $8 | $3.66 | +118.58% | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $581 → $571 | $340.50 | +67.69% | 2 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $250 | $217.49 | +14.95% | 4 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $287 → $235 | $179.45 | +30.96% | 5 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $334 | $187.52 | +78.11% | 5 | Feb 18, 2021 |
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $775 → $856
Current: $806.88
Upside: +6.09%
HealthEquity
Jun 5, 2025
Maintains: Buy
Price Target: $98 → $115
Current: $93.85
Upside: +22.54%
UnitedHealth Group
May 14, 2025
Maintains: Buy
Price Target: $521 → $362
Current: $368.89
Upside: -1.87%
CVS Health
Dec 3, 2024
Upgrades: Buy
Price Target: $66
Current: $82.26
Upside: -19.76%
agilon health
Nov 8, 2024
Maintains: Hold
Price Target: $4 → $2
Current: $0.92
Upside: +116.64%
Hims & Hers Health
Nov 6, 2024
Maintains: Hold
Price Target: $23 → $27
Current: $47.32
Upside: -42.94%
The Cigna Group
Nov 4, 2024
Maintains: Buy
Price Target: $398 → $394
Current: $309.36
Upside: +27.36%
Cardinal Health
Nov 4, 2024
Maintains: Hold
Price Target: $119 → $124
Current: $163.04
Upside: -23.95%
Teladoc Health
Nov 1, 2024
Maintains: Hold
Price Target: $10 → $12
Current: $8.39
Upside: +43.03%
Humana
Oct 3, 2024
Maintains: Hold
Price Target: $349 → $250
Current: $294.51
Upside: -15.11%
Aug 14, 2024
Maintains: Hold
Price Target: $5 → $2
Current: $5.67
Upside: -64.73%
Aug 14, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $39.54
Upside: -21.60%
Aug 9, 2024
Maintains: Hold
Price Target: $7 → $5
Current: $2.89
Upside: +73.01%
Aug 2, 2024
Maintains: Hold
Price Target: $82 → $87
Current: $33.29
Upside: +161.34%
Jul 29, 2024
Maintains: Hold
Price Target: $354 → $353
Current: $162.93
Upside: +116.66%
Sep 5, 2023
Maintains: Buy
Price Target: $461 → $471
Current: $289.42
Upside: +62.74%
Aug 10, 2023
Maintains: Hold
Price Target: $6 → $8
Current: $3.66
Upside: +118.58%
Mar 8, 2023
Maintains: Buy
Price Target: $581 → $571
Current: $340.50
Upside: +67.69%
Mar 23, 2022
Maintains: Buy
Price Target: $255 → $250
Current: $217.49
Upside: +14.95%
Feb 25, 2022
Maintains: Hold
Price Target: $287 → $235
Current: $179.45
Upside: +30.96%
Feb 18, 2021
Maintains: Buy
Price Target: $250 → $334
Current: $187.52
Upside: +78.11%